Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Butyrylcholinesterase ELISA Kit (AC3217)
Cat.#: ASET-1806
Specifications
Description Human Butyrylcholinesterase ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Butyrylcholinesterase concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 1.07 U/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 20-320 U/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2279 Rat GLP-1R ELISA Kit (AC3690) Quantitative inquiry ASET-1529 Human IL-6 ELISA Kit (AC2940) Quantitative inquiry ASET-1508 Mouse Aromatase ELISA Kit (AC2919) Quantitative inquiry ASET-1876 Human TNF Receptor II ELISA Kit (AC3287) Quantitative inquiry ASET-1325 Mouse IL-6 ELISA Kit (AC2736) Quantitative inquiry ASET-2116 Mouse NG2 ELISA Kit (AC3527) Quantitative inquiry ASET-1993 Mouse Caspase-12 ELISA Kit (AC3404) Quantitative inquiry ASET-2197 Human HSD17B1 ELISA Kit (AC3608) Quantitative inquiry ASET-1771 Rat Neuroglobin ELISA Kit (AC3182) Quantitative inquiry ASET-1030 Human Dynamin 1 ELISA Kit (AC2441) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket